Key Takeaways for AXT Stock as of August 2026
- Supply Shock: AXT stock jumped 18% to close at $95.97 on Monday, August 17, after a Taipei industry report flagged the most severe indium phosphide shortage on record, with Q4 wafer prices set to rise more than 10%.
- Split Street: Four analysts currently cover AXT stock, with 3 buys, 1 outperform, and 2 holds, and the $91 mean target now sits below Monday’s close.
- Target Reversal: The Street’s mean target climbed from $3.85 in June 2025 to $96.50 by June 2026, then slipped to $91.00 in August even as the stock kept climbing, pushing the Target/Close ratio under 100% for the first time since March 2026.
- Model Gap: TIKR’s mid-case model values AXT stock at $541 by December 2031, implying 464% total return from the current price of $96, or 49% annualized over 5.4 years.
Why AXT Stock Jumped 18% on an Indium Phosphide Supply Panic
AXT (AXTI) stock climbed 18% to close at $95.97 on Monday, August 17, after a supply-chain report out of Taipei revealed that indium phosphide substrates face their most severe undersupply on record, with fourth-quarter wafer prices set to rise more than 10%. Indium phosphide, or InP, is the compound semiconductor material used to make the lasers and detectors inside high-speed optical transceivers. AXT is one of only two companies that dominate global InP substrate production, alongside Japan’s Sumitomo Electric.
The report landed on a stock already primed to move. AXT posted record second-quarter revenue of $47.6 million on July 30, up 164% year over year, with InP revenue of $30.7 million marking the highest quarterly total in company history. On that call, CEO Morris Young told investors in Q2 2026 earnings call that “customer demand continues to outpace supply no matter how fast we add capacity.” Monday’s pricing report gave that line a fresh price tag. Optics peers moved in sympathy: Coherent gained 8% and Lumentum (LITE) gained 7%, both companies that depend on AXT’s substrate supply to build their own InP lasers.
There was a second, smaller force at work. Tradr ETFs announced new 2x leveraged long and short single-stock funds tracking AXTI, set to debut on Cboe the next day, and that news pulled in anticipatory volume ahead of the launch. But volume alone does not explain an 18% close. The fundamental trigger was the pricing report, and it reframed AXT’s earnings beat from two weeks earlier as the start of a scarcity story rather than a one-quarter spike. That reframing is what the rest of this article has to price.
AXT Stock Now Trades Above Its Own Street Price Target
Four analysts currently cover AXT stock, split between 3 buys, 1 outperform, and 2 holds as of August 17. Their mean target sits at $91, which puts Monday’s $96 close about 5% above the Street’s own number, a gap that flips the usual script where the target sits ahead of the price.
That gap is new. The mean target rose from $3.85 in June 2025 to $30.75 by March 2026 and peaked at $96.50 in June 2026, tracking well ahead of the stock through most of that stretch. Coverage has thinned along the way too, from 5 analysts as recently as Q1 2026 down to 4 today.
By August, the mean target had slipped to $91 even as the price kept rising, a reversal that suggests the same analysts chasing the InP story upward for a year have not yet revised their models for Monday’s pricing report. The Street built this stock’s re-rating for twelve months. Now the stock has outrun the people who built it.
Indium phosphide scarcity just repriced AXT stock in a single session. Pull up the full supply and demand picture on TIKR for free →
TIKR Values AXT Stock at $541, Pricing In Years of InP Growth
TIKR’s mid-case model values AXT stock at $541 by December 2031, implying 464% total return from the current price of $96, or 49% annualized over 5.4 years.
A return profile like that sits far outside anything typical for a semiconductor name; most established chipmakers model annualized returns in the high single digits to low teens, and even fast-growing peers rarely clear 20% annualized in a base case. TIKR’s model is effectively betting that AXT keeps capturing an outsized share of a market that Coherent and Lumentum cannot yet supply for themselves.
The backlog stood above $100 million as of the July 30 call, stretching into 2027 on long-term agreements with Coherent, Lumentum, and Casela, and Monday’s report says the substrate that backlog depends on just got scarcer. The Street’s own $91 target, already sitting below the stock price, says sell-side analysts have not finished catching up to that math.
TIKR’s model sees AXT stock returning 464% by 2031. Check the assumptions behind that target on TIKR for free →
Should You Invest in AXT, Inc.?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up AXT, Inc. stock and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track AXT, Inc. alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Access Professional Tools to Analyze AXTI stock on TIKR for Free →
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
